The duality of oncomiR addiction in the maintenance and treatment of cancer.
about
MicroRNAs as regulators of apoptosis mechanisms in cancerMetformin-induced ablation of microRNA 21-5p releases Sestrin-1 and CAB39L antitumoral activities.MicroRNA and HER2-overexpressing cancer.miR-193a-3p regulates the multi-drug resistance of bladder cancer by targeting the LOXL4 gene and the oxidative stress pathway.MicroRNA-mediated transformation by the Kaposi's sarcoma-associated herpesvirus Kaposin locus.MicroRNAs in Cancer Biology and Therapy: Current Status and Perspectives.Role of microRNA profile modifications in hepatitis C virus-related mixed cryoglobulinemiamiR-26a suppresses tumor growth and metastasis by targeting FGF9 in gastric cancer.MicroRNA silencing for cancer therapy targeted to the tumour microenvironment.Cancer prevention as biomodulation: targeting the initiating stimulus and secondary adaptationsMiR-493 suppresses the proliferation and invasion of gastric cancer cells by targeting RhoC.MicroRNA and Epigenetics: Diagnostic and Therapeutic Opportunities.Therapeutic strategy with artificially-designed i-lncRNA targeting multiple oncogenic microRNAs exhibits effective antitumor activity in diffuse large B-cell lymphoma.Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal CancerMicroRNAs Involved in Anti-Tumour Immunity.Canonical and non-canonical barriers facing antimiR cancer therapeuticsThe miR-199a/Brm/EGR1 axis is a determinant of anchorage-independent growth in epithelial tumor cell lines.Regulation of HSVtk gene by endogenous microRNA-122a in liver cell lines as suicide gene therapy.miR-1 suppresses the proliferation and promotes the apoptosis of esophageal carcinoma cells by targeting Src.Circulating MicroRNA-21 Expression as a Novel Serum Biomarker for Oral Sub-Mucous Fibrosis and Oral Squamous Cell CarcinomaElevated microRNA-185 is associated with high vascular endothelial growth factor receptor 2 expression levels and high microvessel density in clear cell renal cell carcinoma.miR-124-3p acts as a potential marker and suppresses tumor growth in gastric cancer.
P2860
Q26752710-8800830E-97ED-4DFE-B330-5C6D2A31848AQ33885363-CF3D4BEF-AA51-4088-A632-73836260FA21Q33994744-72848D9A-1310-4A87-B1E4-AF6A69513DB3Q34355302-9AE04B36-7D48-430E-B387-FDB2DA524ED6Q34453771-31FCE519-E14A-465F-B352-AEA7FE113C6EQ34599354-AF2C60A8-0EF6-4A22-A815-985706B82593Q34708468-2A5116F0-B605-424B-9ECE-499BE41F4DECQ34981594-79EB06BF-3912-47B0-9BD8-78D7312BD06AQ35201318-A5EBE209-2FD4-4CE0-93D0-02259C470CB0Q36317659-CAF1797B-E4FB-475A-A9FC-46FB42B0ECC2Q36391854-1DE30B52-78D7-495C-B49D-FDD4FB49140CQ36691758-A3075427-A64C-4973-A502-5F0CA4EF0ED8Q37580186-00615B94-8F3A-4A5E-904B-F2EAA2ADA18CQ37611360-CADF6906-344B-4349-BD7F-54EC0A62113FQ38088117-AD8C8A5C-09E1-4340-A5C5-826FFF5A84EAQ38112723-A877A569-6349-4D9D-8EEB-7307C463D6C5Q38910598-46EDC1B8-E177-4A01-87ED-2675C0DC3E5CQ45874176-B056D178-096B-4435-8FA6-4E629CED8500Q47093612-81D82219-9253-4B5B-AC2D-CB28D71302C4Q52560790-59DAD307-17CE-48E4-BBE4-095337A55E21Q54322646-36CC9975-51DB-4ACC-9777-17291FFB6FB3Q55711392-AACD01D9-2224-4514-B97A-F9AFD08C0A4A
P2860
The duality of oncomiR addiction in the maintenance and treatment of cancer.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The duality of oncomiR addiction in the maintenance and treatment of cancer.
@ast
The duality of oncomiR addiction in the maintenance and treatment of cancer.
@en
The duality of oncomiR addiction in the maintenance and treatment of cancer.
@nl
type
label
The duality of oncomiR addiction in the maintenance and treatment of cancer.
@ast
The duality of oncomiR addiction in the maintenance and treatment of cancer.
@en
The duality of oncomiR addiction in the maintenance and treatment of cancer.
@nl
prefLabel
The duality of oncomiR addiction in the maintenance and treatment of cancer.
@ast
The duality of oncomiR addiction in the maintenance and treatment of cancer.
@en
The duality of oncomiR addiction in the maintenance and treatment of cancer.
@nl
P2860
P1433
P1476
The duality of oncomiR addiction in the maintenance and treatment of cancer.
@en
P2093
Christopher J Cheng
Frank J Slack
P2860
P304
P356
10.1097/PPO.0B013E318258B75B
P577
2012-05-01T00:00:00Z